Treatment of Urge Urinary Incontinence in Women After Failure of Cesa or Vasa
NCT ID: NCT01737918
Last Updated: 2015-04-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1/PHASE2
120 participants
INTERVENTIONAL
2013-01-31
2018-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Surgical vs. Medical Treatment of Urge Urinary Incontinence in Women
NCT01737411
Pelvic Floor Muscles and Success in the Surgical Treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse
NCT04029168
Effect of Cystocele Repair With Trans Obturator Tape VS. Trans Obturator Tape Alone on Stress Urinary Incontinence.
NCT06044987
Factors Affecting the Improvement of Severity of Concomitant USI After a Novel TVM Surgery for Women With POP
NCT03607968
Effect of Phenazopyridine on Prolapse Surgery Voiding Trials
NCT03065075
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
trans obturatorial tape (TOT)
placement of a sub-urethral tape
TOT
solifenacin
10 mg per day
solifenacin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TOT
solifenacin
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* stress urinary incontinence
* mixed urinary incontinence
Exclusion Criteria
* avulsion of cesa or vasa tape
* pregnancy
* neurologic/psychological reasons for incontinence
* body weight \>100kg
* syndrome of dry overactive bladder
40 Years
85 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Klinikum der Universität Köln
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Professor Dr. Wolfram Jäger
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wolfram H Jager, PhD
Role: PRINCIPAL_INVESTIGATOR
Study Supervisor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Abt. Beckenbodenchirurgie der Universitäts-Frauenklinik Köln
Cologne, North Rhine-Westphalia, Germany
Abt. Beckenbodenchirurgie der Universitäts-Frauenklinik Köln
Cologne, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
URGE-II
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.